Home/Filings/4/0001104659-19-076290
4//SEC Filing

Shah Preetam 4

Accession 0001104659-19-076290

CIK 0001137883other

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 7:01 AM ET

Size

5.5 KB

Accession

0001104659-19-076290

Insider Transaction Report

Form 4
Period: 2019-12-24
Shah Preetam
EVP, CFO and Treasurer
Transactions
  • Purchase

    Common Stock

    2019-12-24$3.96/sh+11,600$45,92936,600 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.89 to $3.9789, inclusive. The reporting person undertakes to provide to Brainstorm Cell Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

BRAINSTORM CELL THERAPEUTICS INC.

CIK 0001137883

Entity typeother

Related Parties

1
  • filerCIK 0001787403

Filing Metadata

Form type
4
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 7:01 AM ET
Size
5.5 KB